SALT LAKE CITY--(BUSINESS WIRE)--Clinical Innovations, one of the world’s leading medical device companies exclusively focused on labor and delivery and neonatal intensive care, will present an educational forum and participate as an exhibitor at the 2018 Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) Convention. The show takes place June 23-27 at the Tampa Convention Center in Tampa, Florida.
For the third consecutive year, the company will host the “forMOM. forBABY. forLIFE. Educational Forum” featuring top experts discussing industry hot topics in an informal setting. Speakers will include Carol J. Harvey, M.S.; Kris A. Karlsen, Ph.D., APRN, NNP-BC; and Dr. Sean Esplin, M.D.
Clinical Innovations will also be on the exhibit floor (Booth #825), sharing information and giving interactive demonstrations of its market-leading products. Those include the ebb® Complete Tamponade System, a rapid-deployment device that effectively treats postpartum hemorrhage (PPH), as well as the ROM Plus® Rupture of Membranes Test, Kiwi® Vacuum-Assisted Delivery System and babyLance™ Safety heel stick. Attendees will be able to practice using the ebb® with a low-fidelity PPH trainer and with Clinical Innovation’s new PPH e-simulator, which tests users with a variety of scenarios in a virtual operating room setting.
The AWHONN Convention is the largest educational event for women’s health and neonatal nurses in the U.S. More than 3,600 clinicians and 240 exhibitors gather each year for educational programs, leadership training and networking sessions highlighting the latest medical innovations and best practices in neonatal health care.
“Clinical Innovations shares AWHONN’s mission of advancing health care through research, advocacy and education, and the conference is always a great opportunity to connect with the clinicians who use our products every day,” said Jeff Bradford, the company’s vice president of global marketing. “We’re dedicated to helping health professionals achieve the best possible patient outcomes, and our discussions at the conference always leave us inspired to do all we can to meet their needs.”
Clinical Innovations, celebrating its 25th anniversary throughout 2018, has been working to improve the lives of mothers and babies around the world since being established in Salt Lake City in 1993. The company has a presence in more than 90 countries, and its products are used in more than 85 percent of the hospitals in the U.S. and Western Europe.
Clinical Innovations is owned by EQT, a leading investment firm with approximately EUR 50 billion in raised capital across 27 funds.
Since 1969, the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) has been the foremost authority promoting the health of women and newborns and strengthening the nursing profession through the delivery of superior advocacy, research, education, and other professional and clinical resources. AWHONN represents the interests of 350,000 registered nurses working in women's health, obstetric, and neonatal nursing across the United States. Learn more about AWHONN at www.awhonn.org.
About Clinical Innovations
Clinical Innovations is one of the largest medical device companies exclusively focused on labor and delivery and neonatal intensive care. The company is a market-leader in several categories with products such as the Koala® Intrauterine Pressure Catheter, Kiwi® Vacuum-Assisted Delivery System, ROM Plus® Rupture of Membranes Test, traxi® Panniculus Retractor, ClearView® Uterine Manipulator, the babyLance™ Safety heel stick and the ebb® Complete Tamponade System. Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is an EQT portfolio company. For more information, visit clinicalinnovations.com.
EQT is a leading investment firm with approximately EUR 50 billion in raised capital across 27 funds. EQT funds have portfolio companies in Europe, Asia and the U.S. with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT is an active investor and owner in the health care sector, including investments in Certara, Press Ganey, Ottobock, Sivantos, and Lima. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. For more information, visit EQTpartners.com.